Anti-thrombosis Effects and Mechanisms by Xueshuantong Capsule Under Different Flow Conditions

作者：Shu-Xian Han, Ying Chen, Jinyu Wang, Qian Zhang, Bing Han, Yimeng Ge, Yanhua Xiang, Rixin Liang, Xiaoxin Zhu, Yun You, Fulong Liao · 发表于：Frontiers in Pharmacology · 年份：2019 · DOI：10.3389/fphar.2019.00035 · 被引用次数：26 · 研究领域：Platelet Disorders and Treatments、Venous Thromboembolism Diagnosis and Management、Antiplatelet Therapy and Cardiovascular Diseases

Xueshuantong capsule (XST) is a patented traditional Chinese medicine used for the prevention and treatment of thrombosis. The molecular mechanism of XST anti-thrombosis effect through the cross-talk among the platelets/leukocytes, endothelial cells and flow shear stress was investigated. The Bioflux1000 system was used to generate two levels of shear stress: 0.1 and 0.9 Pa. Bioflux Metamorph microscopic imaging system was used to analyze the adhesion cell numbers. Protein expressions were detected by western blot assay and flow cytometry method. The flow-cytometry results showed that, under 0.1 Pa flow, XST decreased ADP induced platelets CD62p surface expression in a dose-dependent manner. Under 0.9 Pa flow, XST at the concentrations of 0.15 g·L-1 reduced the platelets activation by 29.5%; and ASA did not exhibit the inhibitory effect. XST showed similar efficiency on monocytes adhesion both under 0.1 and 0.9 Pa flow conditions, and the inhibition rate was 30.2% and 28.3% respectively. Under 0.9 Pa flow, the anti-adhesion effect of XST might be associated with the suppression of VE-cadherin and Cx43. Under 0.1 Pa, the inhibition on platelets and THP-1 adhesion by XST may be through decreasing VCAM-1 expression. Blood flow performs not only as drug transporter but also exerts its effects to influence pharmacodynamics of XST. Effects of XST inhibiting platelets activation and suppressing platelets/leukocytes adhesion to injured endothelial cells are not only dose-dependent, b...